StockpollyBeta
Get App
Popularity #1,158
RLAY · NASDAQ · Biotechnology

Relay Therapeutics (RLAY)

Designs small-molecule medicines around protein motion for cancer and genetic disease.

$19.24
After hours−0.11 (−0.57%)
At close$19.35(+6.38%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue25010000810730
Cost of revenue81748292776406168110
Gross profit−56−74−72−92−77−648−61−68620
17181892021931613678191
Research & development817782927768746468557176
182020202021191413131115
Selling & marketing040004000000
General & administrative181620202016191412131115
Other expenses−83−80−84−103−77−680−62−68−1−10
Operating income−74−92−90−101−96−85−85−77−80−61−79−91
899989866657
Interest income899989876657
Other non-operating income12211−8−9−8−6−6−6−5−7
Income before tax−66−83−81−92−88−76−77−70−74−55−73−84
Net income from continuing operations−66−83−81−92−88−76−77−70−74−55−73−84
Net income−66−83−81−92−88−76−77−70−74−55−73−84
EPS, basic−$0.54−$0.68−$0.62−$0.69−$0.63−$0.45−$0.46−$0.41−$0.43−$0.32−$0.41−$0.41
EPS, diluted−$0.54−$0.68−$0.62−$0.69−$0.63−$0.45−$0.46−$0.41−$0.43−$0.32−$0.41−$0.41
Weighted average shares, basic122123131133140167169171172172180203
Weighted average shares, diluted122123131133140167169171172172180203
EBITDA−73−93−91−111−87−75−76−69−73−58−73−83
Depreciation & amortization111111111−311
EBIT−75−94−92−112−88−76−77−70−74−55−73−84